169 related articles for article (PubMed ID: 24347522)
1. A network approach to diagnostic biomarkers in progressive supranuclear palsy.
Santiago JA; Potashkin JA
Mov Disord; 2014 Apr; 29(4):550-5. PubMed ID: 24347522
[TBL] [Abstract][Full Text] [Related]
2. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
[TBL] [Abstract][Full Text] [Related]
3. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
Bottero V; Santiago JA; Potashkin JA
J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
[TBL] [Abstract][Full Text] [Related]
4. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
[TBL] [Abstract][Full Text] [Related]
5. Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Vivacqua G; Suppa A; Mancinelli R; Belvisi D; Fabbrini A; Costanzo M; Formica A; Onori P; Fabbrini G; Berardelli A
Parkinsonism Relat Disord; 2019 Jun; 63():143-148. PubMed ID: 30796010
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
8. The ratio of square wave jerk rates to blink rates distinguishes progressive supranuclear palsy from Parkinson disease.
Altiparmak UE; Eggenberger E; Coleman A; Condon K
J Neuroophthalmol; 2006 Dec; 26(4):257-9. PubMed ID: 17204917
[TBL] [Abstract][Full Text] [Related]
9. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
10. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
[TBL] [Abstract][Full Text] [Related]
11. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
[TBL] [Abstract][Full Text] [Related]
12. New and reliable MRI diagnosis for progressive supranuclear palsy.
Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
14. Potential of a new MRI for visualizing cerebellar involvement in progressive supranuclear palsy.
Hara K; Watanabe H; Ito M; Tsuboi T; Watanabe H; Nakamura R; Senda J; Atsuta N; Adachi H; Aiba I; Naganawa S; Sobue G
Parkinsonism Relat Disord; 2014 Feb; 20(2):157-61. PubMed ID: 24172606
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.
Cherubini A; Morelli M; Nisticó R; Salsone M; Arabia G; Vasta R; Augimeri A; Caligiuri ME; Quattrone A
Mov Disord; 2014 Feb; 29(2):266-9. PubMed ID: 24323617
[TBL] [Abstract][Full Text] [Related]
19. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow.
Fukui Y; Hishikawa N; Sato K; Yunoki T; Kono S; Matsuzono K; Nakano Y; Ohta Y; Yamashita T; Deguchi K; Abe K
J Neurol Sci; 2015 Oct; 357(1-2):178-82. PubMed ID: 26227830
[TBL] [Abstract][Full Text] [Related]
20. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
